FDA Adverse Event Malfunction Summary report: N

INOMAX DS (DELIVERY SYSTEM)

MDR report key: 1881815 · Received October 8, 2010

Report

Report Number
3004531588-2010-00087
Event Type
Malfunction
Date Received
October 8, 2010
Date of Event
September 10, 2010
Report Date
October 8, 2010
Manufacturer
INO THERAPEUTICS, LLC/IKARIA
Product Code
MRN
PMA / PMN Number
K061901
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ON (B)(6) 2010, A RESPIRATORY THERAPIST REPORTED THE NITRIC OXIDE (NO) ANALYZER (MONITOR) ON THE INOMAX DS # (B)(4) WAS READING BETWEEN 5 AND 40 PARTS PER MILLION WHILE RUNNING WITH AN OSCILLATOR. EVALUATION SUMMARY PAGE - ON INVESTIGATION, WE WERE UNABLE TO DUPLICATE THE REPORTED CONDITION WITH THIS DEVICE. HOWEVER, ON EXAMINATION OF THE DEVICE SERVICE LOG, FLUCTUATING MONITORED NITRIC OXIDE (NO) VALUES WERE RECORDED. SINCE FLUCTUATING MONITORED NO VALUES HAVE BEEN OBSERVED IN THE SERVICE LOGS OF OTHER DEVICES AND HAVE BEEN LINKED TO FRETTING CORROSION OF AN INTERNAL RIBBON CABLE, THE CABLE WAS REPLACED. THE FRETTING CORROSION CAN LEAD TO INTERMITTENT HIGH RESISTANCE CONNECTION AT THE CABLE'S CONNECTOR, LEADING TO FLUCTUATING MONITORED NO VALUES. IT IS IMPORTANT TO NOTE THAT THE MONITORED NO VALUE WOULD BE FLUCTUATING IN THIS CASE AND NOT THE ACTUAL NO DELIVERED.

Description of Event or Problem · 1

ON (B)(6) 2010, A RESPIRATORY THERAPIST REPORTED THE NITRIC OXIDE (NO) ANALYZER (MONITOR) ON THE INOMAX DS # (B)(4) WAS READING BETWEEN 5 AND 40 PARTS PER MILLION WHILE RUNNING WITH AN OSCILLATOR. THE RESPIRATORY THERAPIST STATES THERE WAS NO HARM TO PATIENT AND NO ADVERSE EVENT OCCURRED. THE DEVICE WAS REPLACED WITH ANOTHER UNIT. THE DEVICE WAS REMOVED FROM SERVICE BY THE CUSTOMER AND IS SCHEDULED TO BE RETURNED TO THE COMPANY FOR INVESTIGATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INOMAX DS (DELIVERY SYSTEM) APPARATUS, NITRIC OXIDE DELIVERY MRN INO THERAPEUTICS, LLC/IKARIA 10003

Patients

Seq Age Sex Outcome Treatment
1